Want to join the conversation?
Research and development (R&D) expense grew 9% due to ongoing development activities for new products and the addition of over 100 new engineering personnel to $GRMN's staff since a year ago. In absolute dollars, R&D costs grew $27.5MM when compared with last year and increased 150 basis points as a percent of revenues versus the year-ago period.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?